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ABSTRACT 
Differential pulse polarographic analysis (DPPA) by using static mercury drop electrode (SMDE) for 
quantification of flucloxacillin (FLUX) in pure and pharmaceutical dosage forms was studied. The optimum 
conditions for the polarographic signal of the different parameters affecting the electrochemical process were 
determined. The best definition of the analytical signals was found in Britton Robinson buffer (0.06 M) at pH 
4.0. Under the optimum conditions, liner calibration graph, Ip=f(CFLUX), was obtained in the concentration 
ranges of 0.1 M (0.0494 μg.mL-1) to 26 M (12.8414 μg.mL-1) at -940 to -1000 mV (versus Ag/AgCl) with 
relative standard deviations (RSD) did not exceed 2.4% for the concentrations of FLUX (0.0494 μg.mL-1). 
Regression analysis showed a good correlation coefficient (R2=9998) between Ip and concentration over the 
mentioned range. The limit of detection (LOD) and the limit of quantification (LOQ) were to be 0.0040 and 
0.0120 μg.mL-1, respectively. The proposed method was validated for linearity, precision and accuracy, 
repeatability, sensitivity (LOD and LOQ), robustness and specificity. The developed method is applicable for 
the determination of FLUX in pure and different dosage forms in presence a same amount of amoxicillin 
(AMOX) with average recovery of 99.4 to 102.2 % and the results are in good agreement with those obtained 
by the HPLC reference method. 
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 INTRODUCTION                .1 
Flucloxacillin [3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl] carbonyl] amino]-3,3dimethyl -7-oxo-4-thia-
1-azabicyclo [3. 2 .0] heptane 2-carboxylate] are the penicillinase-resistant penicillins. It is used as an antibiotic 
[1]. It is normally synthesized for use pharmaceutically usually as the sodium salt and less so, the magnesium 
salt [2 , 3]. Freely soluble in water and in methanol. The chemical formula of flucloxacillin sodium is 
C19H16ClFN3NaO5S.H2O, its molecular weight is 493.9 g.moL-1. The chemical structure of flucloxacillin sodium 
showed in scheme 1. 
 
 
 
 
 
Scheme 1: Chemical structure of Flucloxacillin. 
The hydrolysis of flucloxacillin at pH 4.9 yields a degradation product which is polarographically oxidizable. It 
gives a diffusion-controlled anodic polarographic wave with a half-wave potential at -0.24 V (versus Ag/AgCl) 
[4]. A potentiometric method for determination of flucloxacillin is developed. The method involves 
development of a flucloxacillin sensor with a membrane consisting of Aliquat flucloxacillin as an electro active 
material in poly vinyl chloride matrix membrane plasticized with ortho nitro phenyl-octyl ether or 
dioctylphthalate. The sensor shows fast, stable and reproducible response over the concentration range of 
1.0×10−5 – 1.0×10−2 M flucloxacillin and pH ranges of 6-11 and 7-11 for o-nitro phenyl octyl ether and 
dioctylphthalate plasticized based membrane sensors, respectively [5]. 
The separation was made by a ZORBAX 300-SCX column using 0.025 M ammonium dihydrogen phosphate 
(adjusted to pH 2.6 with phosphoric acid)–acetonitrile (95:5) as mobile phase [6]. A simple, precise, fast and 
accurate HPLC method has been developed for the simultaneous estimation amoxicillin and flucloxacillin in 
capsules. The analytes were resolved, by using a mobile phase mixture of buffer (prepared from 0.001 M         
diammonium hydrogen orthophosphate and 0.04 M tetra butyl ammonium bromide pH adjusted to 7.0±0.1 
with ortho phosphoric acid) and acetonitrile in the ratio (90:10, v/v), on a strong cation exchange column, 
(LUNA SCX, 250mm x 4.6mm I.D. 5 μm particles).The retention times for amoxicillin and flucloxacillin were 
found to be 3.828 and 5.89 min, respectively [7]. 
On the other hand, there are several methods available in the literature for the quantification of flucloxacillin 
including high performance liquid chromatography [6-12], spectrophotometry [13-16] and nuclear magnetic 
resonance spectrometry [17]. 
The SMDE used successfully in polarographic analysis. The SMDE combines the features of the dropping 
mercury electrode (DME) and hanging mercury drop electrode (HMDE): As with the DME, the drops are 
constantly renewed, but during the measurement the drop area is constant as in the HMDE case. In a 
subsequent voltage (U) sweep, the Hg drops are knocked off by the tapping mechanism after the time t. step 
set in the measurement mode. The SMDE is primarily used for sensitive measurements in which the surface of 
the mercury drop must be renewed for every measurement [18]. 
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In the present work, differential pulse polarographic behavior and quantification of the flucloxacillin in pure 
and pharmaceutical dosage forms using a static mercury drop electrode was applied. The method is an easy, 
fast and sensitive for the determination this compound in pure and in pharmaceuticals.                           
2. MATERIALS AND METHODS 
2.1 Equipment and Materials 
A Metrohm 746 VA processor, A Metrohm 747 VA stand with a static mercury drop electrode (SMDE) as a 
working electrode, an auxiliary platinum electrode and a reference electrode, double junction type, (Ag/AgCl) 
saturated with a 3.0 M KCl solution and the three-electrode cell were used. All measurements were done at 
room temperature 25±5oC. Highly pure nitrogen gas (99.999 %) was used for de-oxygenation. pH meter from 
Radiometer company model ion check was used for the studying and monitoring the pH effects. The diluter 
pipette model DIP-1 (Shimadzu), having 100 μL sample syringe and five continuously adjustable pipettes 
covering a volume range from 20 to 5000 μL (model PIPTMAN P, GILSON), were used for preparation of the 
experimental solutions. An ultrasonic processor model Powersonic 405 was used to sonicate the sample 
solutions. Electronic balance (Sartorius-2474; d=0.01 mg) was used for weighing the samples. 
Working reference standard of flucloxacillin (99.2%) was supplied by D.K. Pharma chem. Pvt. Ltd INDIA, 
(Mfg.12-2017, Exp. 11-2020). Lithium perchlorate trihydrate, di-Sodium hydrogen phosphate dodecahydrate, 
Sodium chloride, Sodium hydroxid, Perchloric acid (70%), ortho-Phosphoric acid (85%), Acetic acid (100%), 
Boric acid (100%) were of GR for analysis purchased from MERCK.  
Commercial formulations (as capsule) were used for the analysis of FLUX by using DPPA with SMDE. The 
pharmaceutical formulations were subjected to the analytical procedures: 
(1) Amoxipen capsule, BARAKAT PHARMACEUTICAL, Aleppo–SYRIA, each capsule contains: 250 mg of FLUX 
and 250 mg AMOX (Exp. 03.2020). 
(2) Amoxam capsule, IBN HAYYAN, Homs –SYRIA, each capsule contains: 250 mg of FLUX and 250 mg AMOX 
(Exp. 06.2020). 
(3) Penifloxam capsule, APHAMEA, Hama–SYRIA, each capsule contains: 250 mg of FLUX and 250 mg AMOX 
(Exp. 04.2020). 
(4) Floxin capsule, ALBALSAM PHARMA, Homs- SYRIA, each capsule contains: 250 mg of FLUX and 250 mg 
AMOX (Exp. 04.2020). 
(5) Maxipen capsule, ASIA, Aleppo–SYRIA, each capsule contains: 250 mg of FLUX and 250 mg AMOX (Exp. 
06.2020). 
2.2 Standard stock solutions 
2.2.1 A stock standard solution of flucloxacillin (1x10-4 mol.L-1)  
This solution was prepared by dissolving 49.79 mg from flucloxacillin in 100 mL double distilled deionized 
water (1x10-3 mol.L-1), then dilute 10.000 mL from this solution to 100 mL (1x10-4 mol.L-1).  
2.2.2 Supporting electrolyte 
Britton Robinson, H3PO4-Na2HPO4, lithium perchlorate, sodium chloride as supporting electrolytes (buffers) 
0.200 mol.L-1 at pH (2.5-9.0) were used. 
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2.3 Recommended Procedure 
The stock solutions were further diluted to obtain working solutions daily just before use in the ranges of 
FLUX: 0.100, 0.200, 0.300, 0.400, 0.800, 1.000, 2.000, 4.000, 8.000, 12.000 , 16.000, 20.000, 22.000, 24.000 and 
26.000 μmol.L-1 (0.0494, 0.0988, 0.1482, 0.1976, 0.3951, 0.4939, 0.9878, 1.9756, 3.9512, 5.9268, 7.9024,  9.8780, 
10.8780, 11.8658 and 12.8414 μg.mL-1) by dilution of the volumes: 0.025, 0.050, 0.075, 0.100, 0.200, 0.250, 
0.500, 1.000, 2.000, 3.000, 4.000, 5.000, 5.500, 6.000 and 6.500 mL from stock standard solutions were 
transferred into 25 mL volumetric flask. 7.5 mL of supporting electrolyte were added, and diluted with double 
distilled deionized water to the mark. Ultrapure mercury from Metrohm Company was used throughout the 
experiments.  
2.4 Procedure for pharmaceutical formulations 
Contents of 20 capsules of each studied pharmaceutical formulations were weighted accurately, crushed to a 
fine powder and mixed well. Equivalent weight of contents of one capsule, was solved in 50 mL double 
distilled deionized water by using ultrasonic, filtered over a 100 mL flask and diluting to 100 mL with double 
distilled deionized water, which content as the follows: 2500 μg.mL-1 for all studied pharmaceutical 
formulations content 250 mg/cap. 
These solutions were prepared daily by diluting 100 μL (0.100 mL) from stock solutions of pharmaceutical 
formulations, adding 30 mL from supporting electrolyte, then diluting to 100 mL with double distilled 
deionized water (each solution contents 2.5 μg.mL-1 of FLUX). 
2.5 Analytical procedure 
25 mL of working standard of flucloxacillin or working solutions of pharmaceuticals was transferred to the cell. 
The solution was deoxygenated with N2 gas for 300 s. The potential range studied was from –400 to –1400 mV 
(versus Ag/AgCl) with differential pulse polarographic analysis using static mercury drop electrode in the 
optimum conditions were applied.  
3. RESULTS AND DISCUSSION 
3.1 Differential pulse polarographic behavior 
The polarograms for concentration 0.10-26.0 μmol.L-1 (0.0494-12.8414 μg.mL-1) of FLUX in the optimal 
conditions (supporting electrolytes, pH, scan rate, initial potential, final potential, ...etc.) using DPPA at SMDE 
were studied. The best definition of the analytical signals was found in Britton Robinson (0.06 M) buffer (pH 
4.0) at -940 to -1000 mV (versus Ag/AgCl). 
3.2 The effect of supporting electrolytes (buffer) 
The electrochemical behavior of flucloxacillin was studied in various supporting electrolytes such as (Britton 
Robinson, di-sodium hydrogen phosphate dodecahydrate, lithium perchlorate trihydrate, sodium chloride) 
was studied at pH (2.5-9.0). The best definition of the analytical signals was found in Britton- Robinson buffer 
(pH 4.0) at concentration 0.06 M. The effect of supporting electrolytes (buffer) on the Ip and Ep was studied. 
The values of Ep were -968, -965, -893 and -890 mV for the mentioned buffers, respectively, see Figure 1. The 
effect of the concentration of Britton Robinson was tested over the 4, 8, 10, 20, 30, 35, 40, 50, 60, 70, 80, 90 
and 100 mM. The DPPA at SMDE of 8.0 μM of FLUX with the varying mentioned concentrations of supporting 
electrolyte was studied. The values of Ip increase with increasing concentration of supporting electrolyte of 4 
to 50 mM, then become semi-fixed until concentration of supporting electrolyte 100 mM, while Ep remains 
quasi-static.   
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Fig.1: The effect of buffer solutions on polarograms of FLUX (8.00 μM) using DPPA at SMDE 
O2.3H4LiClO -4 NaCl, -3 ,O2.12H4HPO2Na -2 ,Robinson Britton -1 4.0: pHM) at  6(0.0 buffers   
,meas 32 ms100 mV, t. -s, sweep rate 4 mV/s, U. amplitude  300time  purge, 2N Purge gas(  
t. pulse 35 ms, t. step 2 s, U. step 8 mV, drop size 9, temperature 25°± 5°C). 
 
3.3 The effect of pH 
The influence of pH from 2.5 to 9.0 using Britton Robinson (0.06 M) buffer on Ip and Ep was studied. The values 
of Ip increase with increasing pH value of 2.5 to 4.0, then decrease until pH 6.0 and finally become semi-fixed 
until pH 9.0 . While Ep values are growing a positive value from -1075 mV (when pH 2.5) to -910 mV (when pH 
5.0) then become semi-fixed until pH 9.0 , see Figures 2,3.  
 
 
 
 
 
 
 
 
Fig.2: The effect of pH solution on polarograms of FLUX (8.00 μM) using DPPA at SMDE at pH: 1- 2.5; 2- 3.0;   
3- 3.5; 4- 4.0; 5- 4.5; 6- 5.0; 7- 6.0 and 8- 9.0 using Britton Robinson buffer (0.06 M). (Purge gas N2, purge time 
300 s, sweep rate 4 mV/s, U. amplitude -100 mV, drop size 9, t. meas 32 ms, t. pulse 35 ms, t. step 2 s, U. step 8 
mV, temperature 25°± 5°C). 
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containing buffer  SMDEusing DPPA at M) μ00 .8( of FLUX (b) p(a) and I pFig.3: The effect of pH solution on E
drop  100 mV,-s, sweep rate 4 mV/s, U. amplitude  300, purge time 2M) (Purge gas N 60Robinson (0. Britton
size 9, t. mesa 32 ms, t. pulse 35 ms, t. step 2 s, U. step 8 mV, temperature 25°± 5°C). 
3.4 The effect of negative pulse amplitude (U. ampl) 
The effect of negative pulse amplitude (U. ampl) between -10 to -100 mV on Ip and Ep was studied. Ip linearly 
increases with increasing amplitude value until -100 mV. While Ep stay semi-fixed. The value -100 mV was 
better than another’s. 
3.5 The effect of initial and final potential 
The effect of initial and final potential on the Ip and Ep was studied. It was found that the best initial potential 
was -400 mV and the best final potential was -1400 mV. 
3.6 The effect of temperature and time 
The effect of temperature and time on the electrochemical behavior of FLUX was studied at different values 
(15-35oC and 5-60 min) by continuous monitoring of the Ip. It was found that, the value of Ip was not affected 
by temperature between 20 to 30oC (the temperature at 25±5°C was used). The effect of waiting time was 
determined at laboratory ambient temperature (25±5°C). It was found that, the value of  Ip was not affected by 
time between 5 to 60 min.  
3.7 The effect of time pulse (t. pulse) 
The effect of time pulse (35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 and 100 ms) on polarograms was as the 
follows: Ip decreases with increasing time pulse and Ep has become increasingly positive value (-968 to -944 
mV) with increasing t. pulse. The peak was more symmetrical and Ip was the highest when the t. pulse value of 
35 ms.  
3.8 The effect of time interval for voltage step (t. step) 
It found that the Ip linearly increases with increasing taste (0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.5, 2.0 and    
2.5 s), while Ep has become increasingly positive value (-1006 to -975 mV) with increasing taste. The value of 
the preferred t. step was 2 s. 
3.9 The effect of measurement time (t. meas) 
It found that the Ip increases with increasing t. meas. (2, 4, 6, 8, 10, 12, 16, 20, 24, 28, 30, and 32 ms), while Ep 
remains quasi-static. The value of the preferred t. meas was 32 ms.  
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3.10 The effect of drop size 
It found that the Ip increases slightly with increasing drop size from 1 to 9 size, while Ep stays semi-fixed with 
increasing drop size. The value of the preferred drop size was 9. 
The optimum parameters established for determination of FLUX using DPPA on SMDE showed in Table 1. 
Table 1: The optimum parameters established for determination of FLUX using DPPA on SMDE. 
arametersP Operating modes 
electrode Working Static Mercury Drop Electrode (SMDE) 
Supporting electrolytes (buffer) M 6.00 Robinson Britton 
pH 4.0 
lucloxacillinf of Solvent water double distilled deionized  
Purge gas 2Pure N 
Purge time s 300 
Initial potential mV 400- 
Final potential 1400 mV- 
Scan rate mV/s 4 
t. meas 32 ms 
U. ampl 100 mV- 
t. pulse ms 35 
t. step s 2 
Drop size 9 
Temperature of solution 25°± 5°C 
4. Calibration curves 
Calibration curves for the determination of FLUX using differential pulse polarographic analysis on SMDE with 
negative amplitude in Britton Robinson (0.06 M) buffer at pH 4.0 were applied. One peak was observed in the 
range -940 to -1000 mV (Ep). The peak current (Ip) was proportional to the concentration of FLUX over the 
range 0.0494-12.8414 μg.mL-1 (0.100-26.000 μmol.L-1). The polarograms in the optimum conditions using 
DPPA at SMDE of FLUX at different concentrations are showed in Figure 4. The regression equation was as the 
follows: y=-18.191x-0.5094, R2=0.9998 (y: Ip, nA and x: CFLUX, μg.mL-1), see Figure 5. 
 
 
 
 
 
 
 
 
at pH 4.0  (0.06 M) at Robinson buffer FLUX on SMDE using DPPA in BrittonThe polarograms of  :Fig.4
concentrations: 1- 0.0494, 2- 0.0988, 3- 0.1482, 4-0.1976, 5- 0.3951, 6- 0.4939, 
7- 0.9878, 8- 1.9756, 9- 3.9512, 10- 5.9268, 11- 7.9024, 12- 9.8780, 13- 10.8780, 14- 11.8658  
100 - U. ampls, sweep rate 4 mV/s,  300purge time , 2N Purge gas(1 -12.8414 μg.mL -15and  
mV, t. meas 32 ms, t. pulse 35 ms, t. step 2 s, U. step 8 mV, drop size 9, temperature 25°±5°C). 
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Fig.5: Calibration curves for the determination of FLUX using DPPA on SMDE in the optimum conditions          
(Ip =Ip,total - Ielect). 
5. Analytical results 
Determination of FLUX using DPPA on SMDE in the optimum conditions using analytical curves, Ip=f(CFLUX), 
showed that the accuracy was over the range of FLUX concentration between (0.0494-12.8414 μg.mL-1). The 
relative standard deviation (RSD) not more than 2.4%, see Table 2. Limit of detection (LOD) and limit of 
quantitation (LOQ) for the determination of FLUX by this method were as the follows: 0.0040 and 0.0120 
μg.mL-1, respectively. 
Table 2: Determination of flucloxacillin using differential pulse polarographic analysis on SMDE with negative 
amplitude in Britton Robinson (0.06M) buffer at pH 4.0. 
RSD% 
n
SDt
x
.

, μg.mL-1 
n
SD , μg.mL-1 1-μg.mLSD,  
 
Found 
1-μg.mL, x*  
 
iTaken x 
1-μg.mL μM 
2.4   0.0501±0.00148        
0.00148   
0.00054 0.00120 0.0501 0.0494 0.1 
2.3 .1094±0.00313 0.00113 0.00252 0.1094 0.0988 0.2 
2.2 0.1534±0.00418 0.00151 0.00337 0.1534 0.1482 0.3 
2.1 0.2138±0.00557 
0.00557 
0.00201 0.00449 0.2138 0.1976 0.4 
2.1 0.40 8±0.01045 0.00376 0.00842 0.4008 0.3951 0.8 
2.0 0.5162±0.01282 0.00462 0.01032 0.5162 0.4939 1.0 
2.0 1.0252±0.02545 0.00917 0.02050 1.0252 0.9878 2.0 
1.9 1.9509±0.04760 0.01658 0.03707 1.9509 1.9756 4.0 
1.8 3.8750±0.08659 0.03119 0.06975 3.8750 3.9512 8.0 
1.6 5.9089±0.11737 0.04228 0.09454 5.9089 5.9268 12 
1.6 7.8605±0.15614 0.05625 0.12576 7.8605 7.9024 16 
1.4   9.8944±0.17197       0.06195 0.13852 9.8944 9.8780 20 
1.3 10.9115±0.17610   0.06344 0.14185 10.9115 10.8658 22 
1.3 11.9009±0.19207 0.06918 0.15471 11.9009 11.8536 24 
1.2 12.8355±0.19122 0.06888 0.15402 12.8355 12.8414 26 
         * n=5 t=2.776. 
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6. APPLICATIONS 
Many applications for the determination of flucloxacillin in some Syrian pharmaceutical preparations (in 
presence a same amount of amoxicillin) using differential pulse polarographic analysis on static mercury drop 
electrode with negative amplitude in Britton Robinson 0.06 M buffer at pH 4.0 according to the optimal 
conditions were studied. The amount (m) of FLUX in one capsule was calculated from the following 
relationship: m=h. m', where: m' is the amount of FLUX in capsule calculated according to the regression 
equation of calibration curve, h conversion factors are equal to 100 for all pharmaceuticals content 250 
mg/cap. The results of quantitative analysis for FLUX in pharmaceutical preparations were summarized in 
Tables 3. The proposed method was simple, direct and successfully applied to the determination of FLUX in 
pharmaceuticals without any interference from amoxicillin and excipients. Average assay ranged between 99.4 
to 102.2%. The results obtained by this method agree well with the contents stated on the labels and were 
validated by HPLC method [7]. Therefore, the presented method can be recommended for routine analysis of 
FLUX in pharmaceutical formulations. 
Table 3: Determination of FLUX in some Syrian pharmaceutical preparations using DPPA on SMDE with 
negative amplitude in Britton Robinson 0.06 M buffer at pH 4.0 according to the optimal conditions. 
Commercial name 
of  Label Claim 
 & AMOX, FLUX
mg/cap. 
*Mean ±SD  
(as FLUX),      
mg/ cap. 
RSD% % Assay 
),Assay%( * 
]7[by HPLC 
capsule, Amoxipen 
  BARAKAT 
pharmaceutical 
250   249.40  2.7 99.8 99.5 
capsule,Amoxam  
 AYYANH IBN  
250 250.90  2.6 100.4 100.6 
capsule, Penifloxam 
APHAMEA 
250 255.40 2.6 102.2 102.3 
capsule,Floxin  
ALBALSAM pharma 
250 248.40 2.7 99.4 99.4 
capsule, Maxipen 
ASIA  
250 253.00 2.6 101.2 101.1 
             * n=5, Assay= (found mean/label claim) x100. 
7. Method validation 
The developed method for simultaneous estimation of FLUX has been validated in accordance with the 
International Conference on Harmonization guidelines (ICH) [19]. 
7.1 Selectivity  
Several other components were examined under the conditions that had been optimized for flucloxacillin 
determination. The results appeared that amoxicillin and ampicillin did not interfere when they present at the 
same amount with flucloxacillin. While cloxacillin is interfere. 
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7.2 Linearity  
Several aliquots of standard stock solution of FLUX were taken in different 25 mL volumetric flasks such that 
their final concentrations were 0.0494-12.8414 μg.mL-1 (0.100-26.000 μmol.L-1) for FLUX using DPPA at SMDE 
in Britton Robinson 0.06 M buffer at pH 4.0. Linearity equation obtained was:  y=-18.191x-0.5094, for the 
mentioned range (R2=0.9998).  
7.3 Precision and Accuracy 
The precision and accuracy of proposed method were checked by recovery study by addition of standard drug 
solution to pre-analyzed sample solution at three different concentration levels (80%, 100% and 120%) within 
the range of linearity for FLUX. The basic concentration level of sample solution selected for spiking of the 
FLUX standard solution was 3.951 μg.mL-1. The proposed method was validated statistically and through 
recovery studies, and was successfully applied for the determination of FLUX in pure and dosage forms with 
percent recoveries ranged from 99.9% to 101.6 %, see Table 4.  
Table 4: Results of recovery studies (n=5) 
Level Recovery% 
80% 100.5 
100% 99.9 
120% 101.6 
 
7.4 Repeatability 
The repeatability was evaluated by performing 10 repeat measurements for 3.951 μg.mL-1of FLUX using the 
studied DPPA at SMDE Britton Robinson 0.06 M buffer at pH 4.0 under the optimum conditions. The found 
amount of FLUX (x ± SD) was 3.971± 0.067 μg.mL-1 and the percentage recovery was found to be 100.5±1.7 
with RSD of 0.017. These values indicate that the proposed method has high repeatability for FLUX analysis.    
7.5 Sensitivity (limit of detection [LOD] and limit of quantitation [LOQ]) 
The sensitivity of the presented method was evaluated by determining the LOD and LOQ. The values of LOD 
and LOQ for FLUX are 0.0040 and 0.0120 μg.mL-1, respectively. 
7.6 Robustness 
The robustness of the method adopted is demonstrated by the constancy of the current peak (IP) with the 
deliberated minor change in the experimental parameters such as the change in the concentration of 
excipients, temperature (25±5oC), pH (4.0±0.20), and Celect (0.06±10% mol.L-1) and reaction waiting time (10 
min), see Table 5. This table indicates that the robustness of the proposed method was good (Ip was measured 
and assay was calculated for five times). 
7.7 Specificity  
The specificity of the method was ascertained by analyzing standard FLUX in presence of excipients. These 
findings prove that the suggested methods are specific for determination of the investigated drugs without 
interference from the co-formulated adjuvants. 
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Table5: Robustness of the proposed DPPA method at SMDE for determination of flucloxacillin. 
Experimental parameter 
variation 
Average recovery (%) * 
CFLUX =3.951 μg.mL-1 
Temperature 
20oC 
25oC 
30 oC 
 
99.8 
100.5 
100.6 
pH  
99.8 
100.2 
3.8 
4.2 
CBritton Robinson 
0.054 mol/L 
0.066 mol/L 
 
99.4 
100.3 
reaction time 
10 min 
30 min 
60 min 
 
99.7 
100.4 
101.6 
                                 * n=5. 
7.8 The homogenization of capsule  
The homogenization of capsule in terms of the weight and the amount of drug was studied. It found that the 
mean weight capsule was 0.6965 ± 0.015 g (i.e. ±2.2%), 0.6625 ± 0.011 g (i.e. ±1.7%), 0.7044± 0.021 g (i.e. 
±3.0%), 0.6687 ± 0.015 g (i.e. ±2.2%) and 0.7116 ± 0.0098 g (i.e. ±1.4%) for Amoxipen capsule, Amoxam 
capsule, Penifloxam capsule, Floxin capsule and Maxipen capsule (250 mg/cap). And amount of drug in the 
capsule was 249.00 ± 5.2 mg (i.e. ±2.1%), 250.70 ± 5.2 mg (i.e. ±2.1%), 253.00± 5.5 mg (i.e. ±2.2%), 250.00 ± 
4.0 mg (i.e. ±1.6%) and 254.00 ± 3.0mg (i.e. ±1.2%) for Amoxipen capsule, Amoxam capsule, Penifloxam 
capsule, Floxin capsule and Maxipen capsule (250 mg/cap); which shows that homogeneity of capsule is 
acceptable.  
8. CONCLUSION 
DPPA of FLUX in pure form and in pharmaceutical preparations using SMDE with Britton Robinson 0.06 M 
buffer at pH 4.0 according to the optimal conditions was applied. One peak was observed. Ip is linear over the 
range 0.0494-12.8414 μg.mL-1 (0.100-26.000 μmol.L-1). The relative standard deviation did not exceed 2.4% for 
the concentration 0.0494 μg.mL-1 of FLUX. Regression analysis showed a good correlation coefficient 
(R2=0.9998) between Ip and concentration over the mentioned range. The proposed method was successfully 
applied to the direct analysis of FLUX in pharmaceutical formulations without any interference from excipients 
and the co-formulated adjuvants with adequate accuracy and sensitivity without any pre-separation such as 
extraction.  
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